Targeted Therapies in HER2-Overexpressing Metastatic Breast Cancer

Human epidermal growth factor receptor-2 (HER2) is amplified in 25-30% of breast cancers and is associated with aggressive disease and poorer survival. Multiple anti-HER2 targeted therapies have dramatically changed management and outcome of this subgroup, both in adjuvant and metastatic settings. D...

Full description

Saved in:
Bibliographic Details
Published in:Breast Care (Basel)
Main Authors: Labidi, Soumaya, Mejri, Nesrine, Lagha, Aymen, Daoud, Nouha, El Benna, Houda, Afrit, Mehdi, Boussen, Hamouda
Format: Artigo
Language:Inglês
Published: S. Karger GmbH 2016
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290449/
https://ncbi.nlm.nih.gov/pubmed/28228709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000452194
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items